# Bupropion SR for Treating Smokeless Tobacco Use

> **NCT00414180** · PHASE3 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 225 (—)

## Conditions studied

- Smokeless Tobacco

## Interventions

- **DRUG:** Bupropion SR

## Key facts

- **NCT ID:** NCT00414180
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 225 (—)
- **Last updated:** 2011-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00414180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00414180, "Bupropion SR for Treating Smokeless Tobacco Use". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00414180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*